BackGW Pharmaceuticals Overview

GW Pharmaceuticals Research & Development

Research & Development expenses for GWPH.

Quarterly R&D Expenses

$60.63M
↑ 32.18% YoY

As of Mar 31, 2021

Annual R&D Expenses (TTM)

$220.16M
↑ 39.18% YoY

Trailing 12 months ending Mar 31, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin